PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
The HRI’s top three emphasizes the possibilities of mobile device technologies for do-it-yourself (DIY) healthcare and the potential privacy concerns that could arise.
The list also highlights high-cost patients and the need for innovations that reduce cost and improve outcomes (#’s four and five).
Rounding out the top 10: transparency initiatives targeting clinical trial data, the emerging portrait of the newly-insured, physician “extenders” in the first line of care, redefining health and well-being for the millennial generation and partnerships pushing healthcare companies toward new competitive strategies.
PwC compiles the top list via a survey of 1,000 U.S. consumers and interviews with health industry leaders, according to its press release.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.